TK VETKIT Veterinary Endoscope
"One World, One Health"
TK VETKIT CO., LTD is a wholly-owned subsidiary of Seesheen group. We specialise in animal healthcare and advanced medical devices, including endoscopes and accessories for companion animals, large animals, exotic animals, etc.
By now, our products and services have covered more than 80 countries and regions. TK-VETKIT has not only achieved a strong reputation in the field of veterinary endoscopes, but also gained constant trust and support from domestic and foreign customers with our efforts over the past years.
We shall adhere to the core values of quality, integrity, responsibility and contribute to the advancement and development of pre-clinic and medical clinic applications.
TK VETKIT Veterinary Endoscope
You're Invited to Our Upcoming Spanish Webinar!🚀
TK-VETKIT is honored to welcome our Spanish-speaking Area Ambassador, Dr. Douglas Pinzón MVZ , for an insightful webinar dedicated to the applications of #veterinary #rhinoscopy.🧐
Drawing on his extensive clinical experience in endoscopy and minimally invasive procedures, Dr. Pinzón will explore the diagnostic value of rhinoscopy and share practical approaches to evaluating and managing nasal disorders in #veterinary patients.🐶🐱
📚Explorando las Vías Nasales: El Poder de la Rinoscopia Veterinaria
(Exploring the Nasal Passages: The Power of Veterinary Rhinoscopy)
Join us to discover how rhinoscopy can enhance #diagnostic accuracy, improve #clinical decision-making, and expand your capabilities in veterinary #respiratory medicine.
Don't miss this opportunity to learn from an experienced endoscopist and engage with fellow veterinary professionals from across the Spanish-speaking community.
📅July 16, 2026
🕚19:30 Mexico Time
22:30 Argentina Time
22:30 Chile Time
20:30 Colombia Time
#TKVETKIT #TKVETKITEndoscope #Veterinaria #InnovaciónVeterinaria #webinar #veterinarydiagnostics #VetInnovation #AnimalHealth #VeterinaryMedicine #Endoscopy #Endoscope #endoscopia #pet #webinar
2 weeks ago (edited) | [YT] | 0
View 0 replies